The disproportionate rates of HIV prevalence (CDC, 2005 a,b) and incidence (CDC, 2001) in African American MSM compared to other MSM is puzzling in light of their lower rate of MSM risk behavior.

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

African American MSM exhibit the highest prevalence (CDC, 2005b) and incidence (CDC, 2001) of HIV infection, with Latino MSM exhibiting the next highest rates.

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

The Trump administration eliminated the CDC team that developed national guidelines for prescribing contraception safely for millions of women with underlying medical conditions.

In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community organizations like AVOL Kentucky.

In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community organizations like AVOL Kentucky.

Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier this month revoking notices they received 10 weeks ago that laid them off. Damage to ...

Gilead Sciences announces FDA approval for six-month HIV PrEP injection, Yeztugo. The injection offers over 99.9% effectiveness in HIV prevention.

Anal cancer screening among men who have sex with men with HIV aged 35 years and older appeared cost-effective and could decrease anal cancer incidence and mortality, according to research published ...

Posttraumatic stress disorder in veterans with HIV increases the risk for AIDS and multiple chronic conditions, especially in the first 10 years after diagnosis.

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...